PLEDGE AND SECURITY AGREEMENT dated as of May 26, 2010 between EACH OF THE GRANTORS PARTY HERETO and GOLDMAN SACHS BANK USA, as Collateral AgentPledge and Security Agreement • June 2nd, 2010 • Valeant Pharmaceuticals International • Pharmaceutical preparations • New York
This PLEDGE AND SECURITY AGREEMENT, dated as of May 26, 2010 (this “Agreement”), between Valeant Pharmaceuticals International (the “Borrower”) and each of the subsidiaries of the Borrower party hereto from time to time, whether as an original signatory hereto or as an Additional Grantor (as herein defined) (other than the Collateral Agent, each, a “Grantor”), and Goldman Sachs Bank USA, as collateral agent for the Secured Parties (as herein defined) (in such capacity as collateral agent, together with its successors and permitted assigns, the “Collateral Agent”).
CREDIT AND GUARANTY AGREEMENT dated as of May 26, 2010 among VALEANT PHARMACEUTICALS INTERNATIONAL, CERTAIN SUBSIDIARIES OF VALEANT PHARMACEUTICALS INTERNATIONAL, as Guarantors, GOLDMAN SACHS CREDIT PARTNERS L.P., as Sole Lead Arranger and GOLDMAN...Credit and Guaranty Agreement • June 2nd, 2010 • Valeant Pharmaceuticals International • Pharmaceutical preparations • New York
This CREDIT AND GUARANTY AGREEMENT, dated as of May 26, 2010, is entered into by and among VALEANT PHARMACEUTICALS INTERNATIONAL, a Delaware corporation (“Borrower”), CERTAIN SUBSIDIARIES OF BORROWER, as Guarantors, the Lenders party hereto from time to time, GOLDMAN SACHS CREDIT PARTNERS L.P. (“GSCP”), as sole lead arranger (the “Arranger”), GOLDMAN SACHS BANK USA (“GSB”), as Administrative Agent (together with its permitted successors in such capacity, “Administrative Agent”), as Collateral Agent (together with its permitted successor in such capacity, “Collateral Agent”) and as a Lender.
MEMBERSHIP INTEREST PURCHASE AGREEMENT by and among VALEANT PHARMACEUTICALS INTERNATIONAL, (a Delaware corporation) PRINCETON PHARMA HOLDINGS LLC (a Delaware limited liability company), and The Other Parties Named Herein Dated as of May 3, 2010Membership Interest Purchase Agreement • June 2nd, 2010 • Valeant Pharmaceuticals International • Pharmaceutical preparations • Delaware
THIS MEMBERSHIP INTEREST PURCHASE AGREEMENT (“Agreement”), dated as of May 3, 2010, is by and among Valeant Pharmaceuticals International, a Delaware corporation (“Acquiror”), Princeton Pharma Holdings LLC, a Delaware limited liability company (the “Company”), those Persons listed on Schedule A hereto (individually, each a “Member” and collectively, the “Members” and, the Members collectively with the Company, the “Seller Parties”).
